Mitchell S. Stark

13.3k citations

97 papers · 10.7k · 2 hit papers · h-index 39

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology top 1%
- Cutaneous Melanoma Detection and Management

Papers in

Oncology 47
- Cutaneous Melanoma Detection and Management 42
Cancer Research 28
- Cancer Genomics and Diagnostics 19
- MicroRNA in disease regulation 8

Co-authors: Peer Bork (2 shared papers)Lars Juhl Jensen (2 shared papers)Alexander CJ Roth (2 shared papers)Milan Simonovic (2 shared papers)Tobias Doerks (2 shared papers)Christian von Mering (2 shared papers)Michael Kuhn (2 shared papers)Jean Muller (2 shared papers)
Journals: Journal of Investigative Dermatology (14 papers)British Journal of Dermatology (10 papers)Nature Genetics (5 papers)Genes Chromosomes and Cancer (5 papers)PLoS ONE (5 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mitchell S. Stark

90 papers receiving 10.5k citations

Mitchell S. Stark's Hit Papers

align trajectories log scale

The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored 2010 · 2.9k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2010 Nucleic Acids Research
2008 Nucleic Acids Research

Peers

Countries citing papers authored by Mitchell S. Stark

Since Specialization

Citations

This map shows the geographic impact of Mitchell S. Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell S. Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell S. Stark more than expected).

Fields of papers citing papers by Mitchell S. Stark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell S. Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell S. Stark. The network helps show where Mitchell S. Stark may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell S. Stark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell S. Stark Line = papers co-authored together Mitchell S. Stark links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Research ·Damian Szklarczyk, Andrea Franceschini, Michael Kuhn, Milan Simonovic, Alexander CJ Roth, Pablo Mínguez, Tobias Doerks, Mitchell S. Stark Hit paper breakdown →	2010	2916
2	STRING 8--a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Research ·Lars Juhl Jensen, Michael Kuhn, Mitchell S. Stark, Samuel Chaffron, Christopher J. Creevey, Jean Muller, Tobias Doerks, Philippe Julien Hit paper breakdown →	2008	2043
3	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma Nature ·Satoru Yokoyama, Susan Lesley Woods, Glen M. Boyle, Lauren G. Aoude, Stuart MacGregor, Victoria Zismann, Michael G. Gartside, Anne Elizabeth Cust	2011	370
4	High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL Cancer Research ·Alisa M. Goldstein, May Chan, Mark Harland, Elizabeth M. Gillanders, Nicholas K. Hayward, Marie-Françoise Avril, Esther Azizi, Giovanna Bianchi‐Scarrà	2006	343
5	Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents Journal of Medical Genetics ·May Chan, Mark Harland, Nicholas K. Hayward, Florence Démenais, D. Timothy Bishop, Esther Azizi, Giovanna Bianchi‐Scarrà, William Bruno	2006	338
6	POT1 loss-of-function variants predispose to familial melanoma Nature Genetics ·Carla Daniela Robles‐Espinoza, Mark Harland, Andrew J. Ramsay, Lauren G. Aoude, Vı́ctor Quesada, Zhihao Ding, Karen A. Pooley, Antonia L. Pritchard	2014	318
7	A Single SNP in an Evolutionary Conserved Region within Intron 86 of the HERC2 Gene Determines Human Blue-Brown Eye Color The American Journal of Human Genetics ·Richard A. Sturm, David L. Duffy, Zhen Zhao, Fabio P.N. Leite, Mitchell S. Stark, Nicholas K. Hayward, Nicholas G. Martin, Grant Montgomery	2008	296
8	MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations The American Journal of Human Genetics ·Neil F. Box, David L. Duffy, Wei Chen, Mitchell S. Stark, Nicholas G. Martin, Richard A. Sturm, Nicholas K. Hayward	2001	256
9	Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) Cancer Research ·Jonathan R. Dry, Sandra J. Pavey, Christine A. Pratilas, Chris G. Harbron, Sarah Runswick, Darren Hodgson, Christine M. Chresta, Rose McCormack	2010	215
10	Genome-Wide Loss of Heterozygosity and Copy Number Analysis in Melanoma Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Research ·Mitchell S. Stark, Nicholas K. Hayward	2007	190
11	Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS British Journal of Cancer ·Wieke Zuidervaart, Frans van Nieuwpoort, Mitchell S. Stark, Remco Dijkman, Leisl Packer, A. M. Borgstein, Sandra J. Pavey, Pieter van der Velden	2005	184
12	Common sequence variants on 20q11.22 confer melanoma susceptibility Nature Genetics ·Stuart MacGregor, Grant Montgomery, David Wesley Craig, Zhen Zhao, Kelly Iyadurai, Anjali K. Henders, Nils Homer, Mitchell S. Stark	2008	179
13	Characterization of the Melanoma miRNAome by Deep Sequencing PLoS ONE ·Mitchell S. Stark, Sonika Tyagi, Derek J. Nancarrow, Glen M. Boyle, Anthony L. Cook, David C. Whiteman, Peter G. Parsons, Christopher Schmidt	2010	175
14	Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma JNCI Journal of the National Cancer Institute ·Lauren G. Aoude, Antonia L. Pritchard, Carla Daniela Robles‐Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael G. Gartside, Vı́ctor Quesada	2014	157
15	Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing Nature Genetics ·Mitchell S. Stark, Susan Lesley Woods, Michael G. Gartside, Vanessa Bonazzi, Ken Dutton‐Regester, Lauren G. Aoude, Donald C. Chow, Chris Sereduk	2011	155
16	Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor Pigment Cell & Melanoma Research ·Glen M. Boyle, Susan Lesley Woods, Vanessa Bonazzi, Mitchell S. Stark, Elke Hacker, Lauren G. Aoude, Ken Dutton‐Regester, Anthony L. Cook	2011	151
17	Microarray expression profiling in melanoma reveals a BRAF mutation signature Oncogene ·Sandra J. Pavey, Peter A. Johansson, Leisl Packer, Jennifer M. Taylor, Mitchell S. Stark, Pamela M. Pollock, Graeme J. Walker, Glen M. Boyle	2004	150
18	Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 Nature Genetics ·Stuart MacGregor, Grant Montgomery, Jimmy Z. Liu, Zhen Zhao, Anjali K. Henders, Mitchell S. Stark, Helen Schmid, Mingfeng Zhang	2011	125
19	Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues Molecular and Cellular Biology ·Christine Biondi, Michael G. Gartside, Paul Waring, Kelly A. Loffler, Mitchell S. Stark, Mark A. Magnuson, Graham F. Kay, Nicholas K. Hayward	2004	111
20	Association of Helicobacter pylori Infection With Reduced Risk for Esophageal Cancer Is Independent of Environmental and Genetic Modifiers Gastroenterology ·David C. Whiteman, Priya G Kumari Parmar, Paul Patrick Fahey, Suzanne Moore, Mitchell S. Stark, Zhen Zhao, Grant Montgomery, Adèle C. Green	2010	106

About Mitchell S. Stark

Mitchell S. Stark is a scholar working on Oncology, Cancer Research, Cell Biology, Molecular Biology and Dermatology, having authored 97 papers that have together received 10.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (42 papers), Melanoma and MAPK Pathways (22 papers), Cancer Genomics and Diagnostics (19 papers), melanin and skin pigmentation (16 papers), MicroRNA in disease regulation (8 papers), Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (5 papers) and Skin Protection and Aging (5 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.7k citations), Molecular Biology (6.2k citations), Cell Biology (1.3k citations) and Dermatology (489 citations). Mitchell S. Stark has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Peer Bork, Lars Juhl Jensen, Alexander CJ Roth, Milan Simonovic, Tobias Doerks, Christian von Mering, Michael Kuhn, Jean Muller, Nicholas K. Hayward and Damian Szklarczyk. Their work appears in journals such as Journal of Investigative Dermatology, British Journal of Dermatology, Nature Genetics, Genes Chromosomes and Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mitchell S. Stark

Impact in

Papers in i

In The Last Decade

Mitchell S. Stark

Mitchell S. Stark's Hit Papers

Peers

Countries citing papers authored by Mitchell S. Stark

Fields of papers citing papers by Mitchell S. Stark

All Works

About Mitchell S. Stark

Explore authors with similar magnitude of impact

Papers in